Planning Together: A couple-based prenatal education program for families facing economic hardship
Official title: Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families
Run by University of Tennessee Graduate School of Medicine · NCT07214012 · Data updated 2026-11-12
This pilot test will see if a couple-based, multi-level prenatal contraceptive education program is feasible and acceptable for economically marginalized pregnant people and their partners.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Tennessee Graduate School of Medicine Academic / other |
| Locations | 1 site (Knoxville, Tennessee) |
| Status | Recruiting |
| Started | November 25, 2025 |
| Main results expected | October 14, 2026 |
| Study ends | October 14, 2026 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT07214012 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking pregnant individuals with a consenting, cohabitating partner who can participate and plans to have a future pregnancy after delivery.
✕Probably not a fit
Participants who are not planning future pregnancies with their partner or who are not able to participate with their partner may derive limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study targets short interpregnancy intervals and maternal health disparities by delivering a culturally responsive, couple-focused education program. The intervention combines joint contraceptive education, partner engagement strategies, and ongoing check-ins with online and in-person options, plus tailored community referrals. Feasibility will be judged by accrual, adherence, and completion of education materials, while acceptability will rely on participant satisfaction. Outcomes include changes in contraceptive knowledge, communication quality, and use of contraception, as well as psychological well-being and risk factors related to interpregnancy intervals. The study recruits pregnant individuals around 20 weeks gestation from a university OB clinic and involves their partners in baseline surveys and subsequent sessions.
Why it matters
Potential benefit: If successful, participants may experience improved contraceptive planning and communication, potentially reducing the risk of short interpregnancy intervals and associated adverse outcomes.
How similar studies have gone: Prior studies with couple-based education approaches have shown improvements in communication and contraception use, suggesting potential benefit, though this specific multi-level prenatal program is novel in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient Inclusion Criteria: 1. \> 20 weeks pregnant, age 18+ 2. The pregnant person has an available romantic partner, and the couple was able to get pregnant on their own or will be able to after the delivery 3. separately, the pregnant person reports being in a sexually, psychologically and physically safe relationship 4. English-speaking Romantic Partner Inclusion Criteria: 1. 18 years of age and older 2. Cohabiting with the patient; in a romantic relationship with patient 3. Capable of getting the patient pregnant after delivery 4. Does not need to be the biological father of the current pregnancy 5. English-speaking (in order to take part in the interview as the interviewer does not speak Spanish) Exclusion Criteria: Patient Exclusion Criteria: 1. Participant is under the age of 18 2. Documented cognitive impairment or psychiatric condition in pregnant person's medical record (e.g., severe learning disability, dementia, current psychotic disorder, suicidality) 3. Participation in a concurrent contraceptive education intervention 4. The pregnant person has a high-risk medical condition Romantic Partner Exclusion Criteria: 1. Less than 18 years of age 2. Are not cohabiting with the patient; not in a romantic relationship with patient 3. Not capable of getting the patient pregnant after delivery
Where it's running
-
University of Tennessee Graduate School of Medicine
Knoxville, Tennessee, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body metabolic activity as a predictor of chemotherapy response in epithelial ovarian cancer
This study tests whether whole-body metabolic activity can predict how well epithelial ovarian cancer responds to chemotherapy.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Blood flow restriction exercise program for people with peripheral arterial disease
This will test whether supervised blood flow restriction (BFR) resistance exercise helps adults with peripheral arterial disease walk farther and feel better.
-
Shockwave IVL of the common femoral artery before large-bore TAVR access and closure
This will test whether using Shockwave intravascular lithotripsy on heavily calcified common femoral arteries before TAVR lowers access-site complications for adults with severe aortic stenosis.
-
Perioperative opioid-sparing techniques to speed the start of chemotherapy after open foregut, HPB, or colorectal cancer surgery
This trial will test if intrathecal morphine, quadratus lumborum blocks, or surgeon‑performed TAP blocks help people having open foregut, HPB, or colorectal cancer surgery begin adjuvant chemotherapy sooner.
-
Nebulizer versus dry-powder inhaler long-acting bronchodilator treatment for COPD
This study will test whether a nebulized long-acting bronchodilator combination helps people with symptomatic COPD and air trapping breathe better than the same medicines given by a dry powder inhaler.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.